Jiang R, et al. - Researchers examined atorvastatin for its safety and therapeutic efficacy to treat patients with chronic subdural hematoma (CSDH) nonsurgically. They performed a randomized clinical trial, administering patients either 20 mg of atorvastatin or placebo daily for 8 weeks. Administration of atorvastatin reduced chronic subdural hematomas by 29 mL vs 17 mL for placebo. This suggests that for treating patients with CSDH, atorvastatin may be a safe and efficacious nonsurgical alternative.